CAS 1346623-07-1 | AVAC-008 : Avacopan
(World's Largest Pharmaceutical Supplier)

Everything You Need to Know

CAS 1346623-07-1 is a chemical compound with a unique set of properties and applications. In this article, we'll take a closer look at what this compound is, its chemical properties, and its various applications.

What is CAS 1346623-07-1?

CAS 1346623-07-1 is a chemical compound with the molecular formula C16H25NO2. It is also known by its trade name, which is Buprenorphine. This compound is a synthetic opioid that is primarily used as an analgesic (painkiller) and as a medication for opioid addiction.

Chemical Properties

CAS 1346623-07-1 is a white or off-white crystalline powder that is odorless and almost tasteless. It is soluble in water and ethanol, and it has a melting point of 143-146°C.

One of the unique chemical properties of CAS 1346623-07-1 is its high affinity for the mu-opioid receptor in the brain. This receptor is responsible for mediating the effects of opioids, such as pain relief and euphoria. Buprenorphine has a partial agonist activity at this receptor, which means it produces less of a euphoric effect and has a lower risk of overdose compared to other opioids.

Applications

CAS 1346623-07-1 has several important applications in the medical field, including:

1. Pain Management: Buprenorphine is a potent analgesic that is used to manage moderate to severe pain. It is often used as an alternative to other opioids because of its lower risk of addiction and overdose.

2. Opioid Addiction Treatment: Buprenorphine is also used as a medication-assisted treatment for opioid addiction. It works by reducing cravings and withdrawal symptoms, making it easier for individuals to overcome their addiction.

3. Veterinary Medicine: Buprenorphine is also used in veterinary medicine as a painkiller for animals.

Conclusion

CAS 1346623-07-1 (Buprenorphine) is a synthetic opioid with unique chemical properties and several important applications. It is primarily used as an analgesic and as a medication for opioid addiction. Its partial agonist activity at the mu-opioid receptor makes it a safer alternative to other opioids with a lower risk of addiction and overdose.